Liquidators get court nod to probe Creso Pharma packagers
Liquidators have won court approval to investigate Creso Pharma's former packagers as they pursue over $20 million owed to creditors. Get the full details on the legal pursuit.
Liquidators have won court approval to investigate Creso Pharma's former packagers as they pursue over $20 million owed to creditors. Get the full details on the legal pursuit.
Mayne Pharma's stock plummeted 20% after the government removed key products from the PBS. Discover the full impact on investors and the pharmaceutical sector.
Australian pharmaceutical giant Mayne Pharma faces investor backlash as its controversial US licensing agreement continues to dominate trading, creating clear winners and losers on the ASX.